We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy Evaluation of a Novel Diagnostic Assay Which is the Basis for Seaforia Diagnostic System

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2011 by Lotus Bio Inc..
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00734981
First Posted: August 14, 2008
Last Update Posted: June 23, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Lotus Bio Inc.
  Purpose
Evaluation of specificity and sensitivity of Seaforia- an vitro diagnostic system for evaluating semen quality.

Condition
Male Fertility

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Prospective
Official Title: Efficacy Evaluation of a Novel Diagnostic Assay Which is the Basis for Seaforia Diagnostic System

Further study details as provided by Lotus Bio Inc.:

Primary Outcome Measures:
  • Semen Quality as determined by the following parameters: Semen volume [ Time Frame: The same day as sevan evaluation according to the gold standard ]
  • Semen pH [ Time Frame: The same day as sevan evaluation according to the gold standard ]
  • Leukocytes concentration [ Time Frame: The same day as sevan evaluation according to the gold standard ]
  • Sperm cells concentration [ Time Frame: The same day as sevan evaluation according to the gold standard ]
  • Motile sperm cell concentration [ Time Frame: The same day as sevan evaluation according to the gold standard ]
  • Total motile sperm cells threshold [ Time Frame: The same day as sevan evaluation according to the gold standard ]
  • Sperm cells morphology [ Time Frame: The same day as sevan evaluation according to the gold standard ]

Biospecimen Retention:   None Retained
Semen

Estimated Enrollment: 60
Study Start Date: January 2012
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Detailed Description:

Quantities assessment of semen quality as defined by:

Semen volume, semen pH, leukocytes concentration, sperm cells concentration, motile sperm cell concentration, total motile sperm cells threshold and sperm cells morphology

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Male volunteers
Criteria

Inclusion Criteria:

  • Capable and willing to sign a consent form and participate in the study
  • 20<Age<45
  • Male

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00734981


Contacts
Contact: Arik Kahana, Md. 972-3-5201527 arikk@assuta.com
Contact: Irena Glass 972-3-7643064 irenag@assuta.co.il

Locations
Israel
Assuta Medical Centers Ltd. Not yet recruiting
tel Aviv, Israel, 67443
Contact: Arik kahana, Md.    972-3-5201527    arikk@assuta.com   
Contact: Irina Glass, xxx    972-3-7643064    irenag@asuuta.co.il   
Sponsors and Collaborators
Lotus Bio Inc.
  More Information

Responsible Party: Kahana Arik MD., Assuta Medical Centers Ltd.
ClinicalTrials.gov Identifier: NCT00734981     History of Changes
Other Study ID Numbers: LBI-02-V2
First Submitted: August 12, 2008
First Posted: August 14, 2008
Last Update Posted: June 23, 2011
Last Verified: June 2011